Wikipedia -WSS

Wikipedia

author：entertainment 2025-10-01 00:17:11 - browse：57798

Scientist walks up a strand of DNA -- First Opinion coverage from STAT — Adobe

Eli Lilly said Tuesday that it will pay $200 million to gene-editing firm Beam Therapeutics for Beam’s stake in Verve Therapeutics, another gene-editing company focused on treatments for heart disease.

The deal, which also includes future milestone payments, is evidence that despite the pressure on biotechnology stocks there is still interest in very early cutting-edge technologies among big pharmaceutical players. It also provides Beam, which announced on Oct. 19 that it would cut 100 jobs, or 20% of its workforce, to save cash, a large infusion of money.

“This is like a true win-win-win deal, which is rare in this business, but it’s really, really exciting to see,” said John Evans, Beam’s CEO, in an interview with STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

leisure time

WSS

Novo Nordisk obesity pill bests Wegovy in early trial

Community Health Systems hospitals under DOJ investigation

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

What it’s like to watch children die of measles

Former medical device CEO who sold dummy, plastic parts convicted of fraud

How to bring more disabled researchers into academia

knowledge

Wikipedia

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

How to bring more disabled researchers into academia

Medicare details structure of new drug price negotiation program

With competition flaring, obesity drug hits goal in liver disease study

Peter Hotez and the public health issue of online harassment

Dario to buy mental health app maker Twill in cash and stock deal

New air purifier tech could be key to improving indoor air quality

The problem with charging patients to message their doctors

Jerome Adams on the need for new antivirals for Covid

Former medical device CEO who sold dummy, plastic parts convicted of fraud

hotspot

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Air quality improving but still lags in Black, Hispanic communities

Dario to buy mental health app maker Twill in cash and stock deal

Alabama IVF ruling threatens families facing fatal genetic disease

A new nitrogen execution bill also undermines medical licensing

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

hotspot

leisure time

explore

focus